Upload
mark-rowland
View
217
Download
4
Embed Size (px)
Citation preview
Prevention of malaria in Afghanistan through social marketing
of insecticide-treated nets: evaluation of coverage
and effectiveness by cross-sectional surveys
and passive surveillance
Mark Rowland1,2, Jayne Webster1,2, Padshah Saleh1, Daniel Chandramohan2, Tim Freeman1, Barbara Pearcy1,
Naeem Durrani1, Abdur Rab1 and Nasir Mohammed1
1 HealthNet International, Peshawar, Pakistan2 London School of Hygiene & Tropical Medicine, London, UK
Summary Malaria is often a major health problem in countries undergoing war or conflict owing to breakdown of
health systems, displacement of vulnerable populations, and the increased risk of epidemics. After
23 years of conflict, malaria has become prevalent in many rural areas of Afghanistan. From 1993 to the
present, a network of non-governmental organizations, co-ordinated by HealthNet International, has
operated a programme of bednet sales and re-treatment in lowland areas. To examine whether a strategy
based on insecticide-treated nets (ITN) is a viable public health solution to malaria, communities were
given the opportunity to buy nets and then monitored to determine population coverage and disease
control impact. This was carried out using two contrasting methods: cross-sectional surveys and passive
surveillance from clinics using a case–control design. Nets were purchased by 59% of families. Cross-
sectional surveys demonstrated a 59% reduction in the risk of Plasmodium falciparum infection among
ITN users compared with non-users (OR 0.41; 95% CI 0.25–0.66). The passive surveillance method
showed a comparable reduction in the risk of symptomatic P. falciparum malaria among ITN users
(OR 0.31; 95% CI 0.21–0.47). The cross-sectional method showed a 50% reduction in risk of P. vivax
infection in ITN users compared with non-users (OR 0.50; 95% CI 0.17–1.49) but this effect was not
statistically significant. The passive surveillance method showed a 25% reduction in the risk of
symptomatic P. vivax malaria (OR 0.75; 95% CI 0.66–0.85). ITN appeared to be less effective against
P. vivax because of relapsing infections; hence an effect took more than one season to become apparent.
Passive surveillance was cheaper to perform and gave results consistent with cross-sectional surveys.
Untreated nets provided some protection. Data on socioeconomic status, a potential confounding factor,
was not collected. However, at the time of net sales, there was no difference in malaria prevalence
between buyers and non-buyers. The abundance of Anopheles stephensi, the main vector, did not appear
to be affected by ITN. ITN constitute one of the few feasible options for protection against malaria in
chronic emergencies.
keywords insecticide-treated bednets, malaria, Plasmodium falciparum, Plasmodium vivax, Pakistan
correspondence Mark Rowland, London School of Hygiene & Tropical Medicine, Keppel Street,
London WC1E 7HT, UK. Fax: 00 44 7299 4720; E-mail: [email protected]
Introduction
Controlled trials have demonstrated that insecticide-treated
nets (ITN) can prevent malaria morbidity and mortality
under a variety of epidemiological conditions (Choi et al.
1995; Lengeler 1998). This has stimulated many govern-
ments, UN agencies and non-governmental organizations
(NGOs) to embark upon programmes of net distribution and
treatment (Chavasse et al. 1999). While the utility of ITN
is no longer in doubt, it is far from certain whether delivery
and sales through the less controlled conditions that exist
within development projects, or through the private
sector, can approach the same coverage and impact as
carefully executed trials (D’Alessandro et al. 1995; Lengeler
Tropical Medicine and International Health
volume 7 no 10 pp 813–822 october 2002
ª 2002 Blackwell Science Ltd 813
& Snow 1996). The degree of uncertainty is still greater
when the country being targeted is undergoing civil conflict
or just emerging from conflict. Such places are increasingly
the subject of internationally aided ITN distribution
projects, yet no evidence has been gathered to indicate that
such distributions have any impact on malaria (Rowland &
Nosten 2001). As ITN projects continue to grow in size and
number in both politically stable and unstable environments,
methods for monitoring effectiveness and coverage become
paramount to monitor progress and as a means for
improving strategy.
Until the last decade, the use of bednets in Afghanistan
was uncommon (Rowland et al. 1996). But with the
country racked by 20 years of war, the public health
system in disarray, and malaria becoming a major national
problem, a strategy based on ITN for personal protection
seemed the only feasible solution (Rowland et al. 1997).
An efficacy trial in the secure environment of an Afghan
refugee camp just over the border in Pakistan demonstrated
that Afghans were ready to adopt the habit and stood to
gain up to 70% protection against Plasmodium falciparum
and 56% protection against P. vivax infection (Rowland
et al. 1996). In 1992, HealthNet International (HNI)
initiated social marketing of ITN through a network of
district clinics run by several international and local NGOs
in the eastern region of the country.
Within 2 years, the programme’s initial objective of
seeding demand across the region had been achieved, and
the sales revenue generated was contributing towards
restocking of nets. Popularity and progress was such that the
network began to consider whether a malaria control
strategy based on sale of ITN could achieve a coverage and
epidemiological impact significant enough to replace the old
strategy of indoor residual spraying with DDT that existed
before the war. Groups of villages were given the oppor-
tunity to buy nets over a 2-year period. To measure impact,
two methods were compared: the first involved repeated
cross-sectional malaria parasite surveys among net-using
and non-using families, the second involved passive sur-
veillance of malaria cases at district clinics. A variant on the
first method has recently been applied in Tanzania to
evaluate the effectiveness of community-based ITN social
marketing (Abdulla et al. 2001). The second method has
been applied in Afghan refugee camps to evaluate the long-
term effectiveness of ITN (Rowland et al. 1997).
Methods
Study area
The study was conducted in the rural districts of Behsud
and Chaprahar in Nangarhar province, eastern Afghanistan
(Figure 1). By the early 1990s the focus of the war had
shifted to the centre and north of the country and the east
had become secure. Most villages in Nangarhar had been
partly destroyed during fighting but by 1995, the first year
of the study, many inhabitants had returned from refugee
camps in Pakistan, their homes rebuilt, the area de-mined,
irrigation systems repaired, and agriculture stepped up.
Agriculture was the main livelihood. The main crops grown
were wheat from March to May, rice from June to
November, and vegetables. Some farmers grew opium
poppy.
Nangarhar marks the western edge of the monsoon
rains, which fall in July and August. Rivers are also snow-
fed. The main malaria vectors in eastern Afghanistan are
Anopheles stephensi, A. fluviatilis, A. culicifacies, and
A. pulcherrimus (Rowland et al. 2002). In Behsud and
Chaprahar, these species breed in or around rice fields from
June onwards. Malaria is both seasonal and unstable in
Afghanistan, and outbreaks often occur in areas lacking
clinical services. P. vivax accounts for 85% and
P. falciparum for 15% of malaria infections. Incidence of
P. vivax reaches a peak in August, P. falciparum in
October – November, with transmission of both species
continuing until the end of the year (Rowland et al. 2002).
Chloroquine resistant P. falciparum is widespread (Rab
et al. 2001), and is partly responsible for its resurgence in
the last decade (Shah et al. 1997).
The interventions
The sequence of activities is summarized in the flow chart
(Figure 2). Criteria for selecting the two study areas were
presence of extensive rice culture and thus vector breeding,
reputable NGO clinics able to diagnose malaria using
microscopy, and little or no previous targeting with nets.
Nets were introduced in a stepped manner in six villages
from Behsud and in six villages from Chaprahar districts.
Three of six villages from each district were randomly
selected to receive nets in June 1995 and the other three
received nets in June 1996. The purchase price per net was
8000 afghanis (US$2.9) in 1995, increasing to 35 000
afghanis (US$3.3) in 1996 as a result of inflation. This
constituted a 25% subsidy on the manufacturer’s price.
A village was given a day’s advance notice of the arrival of
a mobile sales team, with the news being broadcast from
the mosques’ minarets. On arrival, the team gave a public
health education session about malaria and the use of ITN
using illustrated silk screen flip charts, registered the
families who wanted to buy, and treated the nets in full
public view. This mode of implementation was the
standard approach used by HNI during day-to-day sales
operations. The 12 villages were randomized with eight
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
814 ª 2002 Blackwell Science Ltd
being offered ITN (polyester nets treated with either
permethrin 500 mg/m2 or lambdacyhalothrin 25 mg/m2)
and four being offered untreated nets (UTN). Treatment
was free at the time of sales, but re-treatment was offered
for US$0.05 per net in both 1996 and 1997.
Cross-sectional parasite surveys were conducted in June
and November of 1995 and 1996. Villages were census-
surveyed and 25 households from each village were
randomly selected from the enumeration lists. Blood
smears were taken from all household members present on
the day of survey, and each individual was asked whether
they had been using a bednet recently (during the last
fortnight). Individuals were classified as bednet users or
non-users according to their response. About 15% of all
households were sampled at each survey. Households were
randomly selected anew from the enumeration list before
each new survey. Individuals positive for malaria parasites
were treated with chloroquine (25 mg per kg body weight
in divided doses).
Passive surveillance of malaria was carried out from July
1995 to December 1997 through two clinics in Behsud and
two clinics in Chaprahar. Microscopy was performed
routinely on all patients presenting with a history of fever
suspected of being malaria. Patients were asked whether
they had been using a bednet recently. Positive cases were
treated with chloroquine. Ideally, each patient would have
been questioned about socio-economic status, in order to
adjust for this potential confounder later on. But this
would have placed an extra workload on the clinic staff
and difficult to monitor. To raise diagnosis of malaria to a
consistent standard, all microscopists received refresher
training at the start of the study. Their performance was
monitored monthly by taking samples of slides for
re-examination and quality control.
For entomological surveillance, 15 sentinel houses were
randomly selected from the enumeration list of each
village, and collections of mosquitoes were made once a
month by space-spray pyrethroid aerosol in a sleeping
room and animal shed of each house. Collections were
identified to species and scored. The same houses were
monitored throughout.
Statistical analysis
We grouped the villages according to intervention received:
(1) ITN from June 1995 onwards; (2) UTN from June 1995
AFGHANISTAN BY PROVINCE
PAKISTAN
Figure 1 Map of eastern Afghanistan andbednet trial area.
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
ª 2002 Blackwell Science Ltd 815
onwards; (3) ITN from June 1996 onwards, and (4) UTN
from 1996 onwards. We compared the odds of parasita-
emia in bednet users vs. non-users within these groups. For
the analysis of passive data, individuals presenting with
symptoms of malaria and a smear positive for malaria
parasites were classified as cases, distinguishing between
falciparum and vivax. Patients presenting with possible
symptoms of malaria at the same health centres during the
same period, but with a negative smear, were classified as
controls. We fitted logistic regression models adjusting for
the effect of age, sex, village and district, and estimated the
odds ratio (OR) of bednet use among cases compared with
controls.
With entomological data, the monthly totals of each
village were log transformed and analysed using Poisson
regression.
Results
Net sales and coverage
In total, 1680 households and 14 538 people from 12
villages were involved in the study. Population character-
istics of the four village groups are shown in Table 1.
Twelve per cent of families (209/1680) had bought
nets prior to the study. Within the six villages offered
nets in year 1, 56% (530/954) of families took up the
offer (range between villages 46%)83%) (Table 2). The
following year 108 families bought nets a second time,
but only 36 families were first time buyers, indicating a
rapid penetration and saturation of the households
willing or able to buy. Among the six villages offered
nets in year 2 for the first time, a similar proportion
took up the offer (54%, range 35%)72%). Seventy-one
per cent (95% CI: 61%)79%) of families that took up
the offer had purchased sufficient nets to cover their
entire family. Re-treatment rates among village groups
buying ITN were 64% (193/302) in year 2 and 47%
(154/329) in year 3, despite only a nominal charge being
levied (Table 2).
Cross-sectional surveys
The prevalence of malaria at admission in June 1995 is
shown in Table 1. The commoner species in mid summer
was P. vivax. Both species were more prevalent in the
10–14-year age group and less prevalent in adults. Malaria
was three to four times more prevalent in Behsud than in
Chaprahar, and approximately 1.5 times more prevalent in
village groups 2 and 3 than in groups 1 and 4. At the time
of the second survey, nets had been in use for 5 months in
village groups 1 and 2. In neither group was a significant
effect of nets observed against either species of malaria
(Table 3).
April 1995
Selection of 12villages from 2districts withinthe catchmentareas of 4clinics
May 1995
(1) Enumerationof households
(2) Training ofVHWs andmicroscopists
June 1995
(1) X-sectionalmalaria survey -1
(2) Randomizationof villages intofour study groups
June–July1995
November1995
X-sectionalmalariasurvey- 2 inall 12 studyvillages
June–July1996
Oct – Nov1996
Passivesurveillancecommences in 2villages ofBehsud andChaprahar
Group 1(1) Sale ofsubsidised nets(2)Treatment ofnets withinsecticide
Group 1(1) Sale ofsubsidised nets(2)Treatment ofnets withinsecticide
Group 2(1) Sale ofsubsidised nets
Group 2(1) Sale ofsubsidised nets
Group 3(1) Sale ofsubsidised nets(2)Treatment ofnets withinsecticide
Group 4(1) Sale ofsubsidised nets
June– July1996
X-sectionalmalariasurvey-3 inall 12 studyvillages
X-sectionalmalariasurvey-4 inall 12 studyvillages
Figure 2 Key activities flow chart.
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
816 ª 2002 Blackwell Science Ltd
At the time of the third survey, a significant effect of ITN
was becoming evident against P. vivax in group 1,
prevalence being almost threefold less among net users
than among non-users. The vivax cases presenting at this
time would have been transmitted in the previous summer–
autumn when nets were already in use. Within groups 3
and 4, where nets had been purchased only a week before,
there was no difference in P. vivax prevalence between
net-using and non-using groups. This was an important
finding because it indicated that within these villages there
appeared to be no inherent difference in malaria risk
between families that chose to buy nets and those that
chose not to. Hence any subsequent difference in malaria
prevalence arising between users and non-users in later
surveys would probably be an effect of net use rather than
unknown socioeconomic or behavioural factors.
At the time of the fourth survey, the prevalence of
P. falciparum was significantly less in net users than in non-
users in three of four groups, and even in the fourth
group the trend was in the same direction as the others.
Overall, there was a 59% reduction in the odds of
P. falciparum parasitaemia in net users compared with
non-users after adjusting for other predictors (OR 0.41,
95% CI 0.25–0.66). The OR for P. vivax in net users vs.
Table 2 Uptake of nets and re-treatment in the four village-intervention groups
IndicatorsGroup 1n (%)
Group 2n (%)
Group 3n (%)
Group 4n (%)
Number of families buying nets in 1995 302 (59%) 228 (52%) 0 0Number of nets sold in 1995 1339 806 0 0Average number of persons per net in net owning families in 1995 2.1 2.5 – –Number of families buying nets for the first time in 1996 25 (5%) 11 (2.5%) 255 (68%) 135 (39%)Number of nets sold in 1996 250 142 730 395Average number of persons per net in net owning families in 1996 2.0 2.2 2.9 2.5Number of families re-treating nets in 1996 193 (64%) – – –Number of nets re-treated in 1996 816 (61%) – – –Number of families re-treating nets in 1997 154 (47%) – 138 (54%) –Number of nets re-treated in 1997 388 (24%) – 326 (45%) –
Table 1 Baseline characteristics
Characteristics Group 1 Group 2 Group 3 Group 4
Number of villages 4 2 4 2Number of households 514 440 378 348Mean household/village (range) 128 (77–176) 110 (46–248) 189 (153–225) 174 (43–305)Total population 4852 3824 3158 2580Mean population/village (range) 1213 (644–1999) 956 (293–1486) 1579 (1288–1990) 1290 (313–2268)Mean household size 9.4 8.7 8.4 7.4
Age distribution (%)0–4 years 549 (21) 448 (22) 268 (21) 287 (21)5–9 years 623 (23) 504 (25) 360 (28) 363 (26)10–14 years 298 (11) 271 (13) 173 (13) 164 (12)14+ years 1197 (45) 817 (40) 497 (38) 576 (41)Mean age 18.3 17.3 16.9 17.3Male:Female ratio 46:54 48:52 50:50 47:53
Baseline parasite prevalenceSample size 2272 1728 1079 1286Positive for P. falciparum (%) 17 (0.7) 16 (0.8) 15 (1.2) 5 (0.4)Positive for P. vivax (%) 170 (6.9) 184 (9.5)* 128 (10.5)* 97 (7.0)
Group 1: Insecticide-treated nets (ITN) from June 1995 onwards.Group 2: Untreated nets (UTN) from June 1995 onwards.Group 3: ITN from June 1996 onwards.Group 4: UTN from June 1996 onwards.* Significantly different compared to group 1 (P < 0.01).
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
ª 2002 Blackwell Science Ltd 817
non-users in group 1 had increased from 0.29 to 0.50
during the fourth survey. A significant effect against P.
vivax was evident when groups 1 and 3, which had been
using ITN, were combined (OR 0.38, 95% CI 0.20–0.74),
but not in groups using UTN (Table 3).
Overall, the prevalence of P. vivax reduced from 4.4%
(52/1143) in the second survey to 2.6% (21/1313) in the
fourth survey among net users while it remained relatively
stable from 3.4% (61/1811) to 3.2% (78/2527) among
non-users. The prevalence of P. falciparum remained stable
from 1.9% (25/1143) to 2.2% (25/1313) among net users
while it increased from 3.8% (68/1811) to 4.7% (78/2527)
among non-users.
Passive surveillance
Figure 3 shows the relationship between the monthly
variation in bednet use, mean temperature, and mosquito
density during 1995 and 1996. During the winter months
net users comprised less than 5% of clinic attenders. Peak
attendance by users was in August 1996 (36.0%). Net use
rates correlated both with monthly changes in mosquito
abundance (r ¼ 0.78) and with ambient temperature
(r ¼ 0.87). Despite the hot, stuffy summer nights, net
owners were presumably making use of nets to protect
themselves against the greater discomfort caused by
mosquito biting.
The passive surveillance study confirmed that the
differences in the distribution of age and sex between net
users and non-users were negligible. Net use grew from
24% (1429/6023) in 1995 to 34% (1470/4300) in 1997.
The odds of malaria infection was greater for the 5–14-
year age groups than for the 0–4-year and >15-year age
groups, and greater for females than for males. The odds of
infection were lower for village group 1 that had used ITN
for 3 years, and was lower for year 3 than for years 2 and 1
(Table 4). There was a negative association between use of
bednets and malaria (OR 0.34 for P. falciparum and 0.89
for P. vivax). There was a significant protective effect of
nets against P. falciparum in all village groups except for
group 4 that had received UTN only in year 2 (Table 5).
A significant protective effect against P. vivax was only
apparent in the village group 1 that had used ITN since
1995.
Table 3 Cross-sectional study: comparison of parasitaemia between net users and non-users in the four village-intervention groups
Parasite negative inP. falciparum positives(% positive) in
P. vivax positives(% positive) in OR� of P. falciparum
in net users vs.non-users
OR� of P. vivaxin net users vs.non-usersIntervention groups Users Non-users Users Non-users Users Non-users
Survey 2Group 1 (ITN)� 707 499 12 1.7 14 (2.7) 29 (3.9) 22 (4.2) 0.59 (0.27–1.30) 0.95 (0.54–1.99)Group 2 (UTN)§ 207 261 5 (2.4) 8 (3.0) 13 (5.9) 10 (3.7) 0.78 (0.25–2.45) 1.64 (0.69–3.91)
Survey 3Group 1 (ITN)– 1147 366 1 (0.1) 1 (0.3) 17 (1.5) 16 (4.2) 0.34 (0.02–5.6) 0.29 (0.14–0.59)**Group 2 (UTN)�� 462 206 0 (0) 0 (0) 32 (6.5) 5 (2.4) – 2.79 (1.06–7.38)*Group 3 (ITN)�� 784 415 5 (0.6) 1 (0.2) 52 (6.2) 21 (4.8) 2.74 (0.30–60.1) 1.24 (0.74–2.13)Group 4 (UTN)§§ 206 308 1 (0.5) 0 (0) 6 (2.8) 9 (2.8) – 1.01 (0.35–2.90)
Survey 4Group 1 (ITN)–– 591 812 6 (1.0) 20 (2.4) 4 (0.7) 11 (1.3) 0.41 (0.17–1.00)* 0.50 (0.17–1.49)Group 2 (UTN)��� 143 422 4 (2.7) 19 (4.3) 5 (3.4) 10 (2.3) 0.65 (0.23–1.86) 1.54 (0.54–4.39)Group 3 (ITN)��� 366 757 10 (2.7) 42 (5.3) 7 (1.9) 36 (4.5) 0.49 (0.25–0.98)* 0.40 (0.18–0.89)*Group 4 (UTN)§§§ 172 352 0 (0) 18 (4.9) 5 (2.8) 8 (.2.2) 0.00 (0.00–0.44)** 1.27 (0.43–3.77)
� Odds ratios adjusted for the effect of age, sex and district.� Treated net was in use for 5 months.§ Untreated net was in use for 5 months.– Treated net was in use for 12 months.�� Untreated net was in use for 12 months.�� Treated net was in use for < 1 month.§§ Untreated net was in use for < 1 month.–– Treated net was in use for 17 months.��� Untreated net was in use for 17 months.��� Treated net was in use for 5 months.§§§ Untreated net was in use for 5 months.*P < 0.05; **P < 0.01.
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
818 ª 2002 Blackwell Science Ltd
Individual protective effectiveness [IPE ¼ (1 ) OR)%]
of ITN against P. falciparum infection from the cross-
sectional surveys and the passive surveillance case–control
study were 59% and 69%, respectively, and against
P. vivax 50% and 25%, respectively. Community
protective effect (CPE) is defined as the product of
Table 4 Case–control study based on passive surveillance at district clinics
Predictors ControlsCases P. falciparum(% positive)
Cases P. vivax(% positive) OR� P. falciparum OR� P. vivax
Age group0–4 4259 71 (1.6) 682 (14) 1.0 1.05–9 3400 159 (4.5) 812 (19) 2.7 (2.0–3.6)*** 1.6 (1.4–1.7)***10–14 2094 90 (4.1) 450 (18) 2.4 (1.8–3.4)*** 1.4 (1.2–1.6)***15+ 7963 233 (2.8) 1186 (13) 1.8 (1.4–2.4)** 1.0 (0.9–1.1)
SexMale 10351 273 (2.6) 1634 (14) 1.0 1.0Female 7429 280 (3.6) 1506 (17) 1.4 (1.2–1.7)*** 1.2 (1.1–1.3)
DistrictBehsud 13804 343 (2.4) 1614 (11) 1.0 1.0Chaprahar 3988 210 (5.0) 1526 (28) 0.49 (0.41–0.59)*** 0.33 (0.30–0.35)***
Village group1 12074 212 (1.7) 1507 (11) 1.0 1.02 3325 202 (5.8) 863 (21) 3.0 (2.5–3.7)*** 1.9 (1.7–2.0)***3 1094 93 (7.8) 304 (22) 4.2 (3.2–5.4)*** 2.0 (1.7–2.3)***4 1211 40 (3.2) 456 (27) 1.5 (1.0–2.1)* 2.6 (2.3–3.0)***
Period1995 4175 336 (7.4) 1519 (27) 1.0 1.01996 3869 150 (3.7) 751 (16) 0.67 (0.54–0.83)*** 0.69 (0.63–0.77)***1997 4293 28 (0.6) 241 (5) 0.10 (0.07–0.15)*** 0.18 (0.15–0.21)***
BednetNon-users 11263 479 (4.1) 2335 (17) 1.0 1.0Users 4537 55 (1.2) 723 (14) 0.34 (0.26–0.46)*** 0.89 (0.81–0.97)**
�All the predictors shown in the table were included in the logistic model.* P < 0.05; ** P < 0.01; *** P < 0.001.
40
35
30
25
20
15
10
5
0Jul Oct Jan Apr Jul Oct
1995–1996
% using nets Mosquito density (% of total caught) Mean temperature (˚C)Figure 3 Relationship between net usage,mosquito density and temperature.
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
ª 2002 Blackwell Science Ltd 819
IPE · net coverage (Lengeler & Snow 1996). Net coverage
estimates obtained from the cross-sectional survey and
passive surveillance were 57% and 34%, respectively.
Thus the CPE of ITN was 20.1% against P. falciparum and
17.0% against P. vivax from cross-sectional surveys and
23.5% against P. falciparum and 8.5% against P. vivax
from passive surveillance.
Entomology
Mosquitoes were more numerous in animal sheds than
in sleeping rooms (Table 6). Mosquitoes were 3.4 times
more abundant in animal sheds in 1996 than in 1995
(P < 0.001), but were not significantly more abundant in
sleeping rooms in 1996 than in 1995. There was no
significant effect on mosquito density of ITN over UTN or
of ITN over no-nets in sleeping rooms or animal sheds
in 1995. However, in 1996, there was a significant effect
of ITN over UTN in sleeping rooms (rate ratio 0.55,
95% CI: 0.33–0.92, P ¼ 0.03). This effect of ITN was not
apparent in animal rooms (P ¼ 0.45) and thus ITN did
not appear to reduce mosquito densities overall.
Discussion
Repeated cross-sectional surveys and case–control methods
based on passive surveillance demonstrated that bednets
were less protective against P. vivax than against
P. falciparum. An effect against P. vivax infection was not
evident in every cross-sectional survey, and may take a few
seasons to become apparent probably because of relapses
from earlier infections masking the effect. An effect of nets
against P. falciparum infection was more immediately
apparent. UTN conferred some protection against malaria,
and this conforms with recent evidence from Africa
(Abdulla et al. 2001; Armstrong-Schellenberg et al. 2001;
Clarke et al. 2001).
Cross-sectional surveys were a more expensive method
of monitoring. Passive surveillance is more efficient
because the only additional task is to ask questions about
net usage in addition to the routine clinical history. Thus,
passive surveillance would be preferable if the two methods
were able to give similar results.
There were two important differences between the two
study designs. Whereas cross-sectional surveys directly
assessed a representative sample of the target population,
passive surveillance monitored a more restricted source
population, i.e. one that had fever and which chose to seek
treatment at one of the clinics involved in the study.
Secondly, whereas passive surveillance measured sympto-
matic parasitaemia, cross-sectional surveys measured both
symptomatic and asymptomatic parasitaemia. Despite this,
the fact that the IPE of ITN derived from the final survey
and from the passive surveillance case–control study were
similar (59% and 69%, respectively) seems to indicate that
the clinic attender study population was representative of
the target population.
If there were any reason why net users should be more or
less prone to episodes of fever, not related to malaria, than
non-users, selection bias would be introduced. It is
conceivable that a family bednet used by several people
would provide a better environment for the spread of
infectious agents such as respiratory viruses. If this were so,
net users might experience more episodes of fever unrelated
to malaria, and this would lead to an overestimation of the
protective effect of bednets. To our knowledge this has
never been studied.
Table 5 Passive surveillance case–control study: effect of use of bednets on clinical malaria in the four village-intervention groups
Controls P. falciparum cases P. vivax casesOR� of net use inP. falciparum cases
OR� of net use inP. vivax casesIntervention groups Users Non-users Users Non-users Users Non-users
Group 1 (ITN)� 3467 6810 26 169 395 1042 0.31 (0.21–0.47)** 0.75 (0.66–0.85)**Group 2 (UTN)� 267 813 9 84 88 216 0.33 (0.16–0.67)* 1.22 (0.92–1.64)Group 3 (ITN)§ 661 2499 16 184 192 661 0.34 (0.21–0.58)** 1.11 (0.92–1.33)Group 4 (UTN)§ 127 1073 4 36 45 409 1.15 (0.40–3.31) 1.01 (0.70–1.45)
� Adjusted for the effect of age, sex, district and study period.� Most nets were in use for 30 months from July 1995 to December 1997.§ Nets were in use for 18 months from July 1996 to December 1997.*P < 0.01; **P < 0.001.
Table 6 Mosquito density per room: Anopheles stephensigeometric means (95% confidence interval)
Villagegroup
Bedroom Animal shed
1995 1996 1995 1996
1 0.6 (0.5–0.8) 0.8 (0.7–1.0) 1.3 (1.0–1.6) 4.5 (3.7–5.3)2 0.7 (0.5–1.0) 1.2 (0.9–1.5) 1.5 (1.1–2.0) 7.4 (6.0–9.1)3 0.6 (0.4–0.7) 0.6 (0.5–0.7) 1.5 (1.2–1.9) 4.3 (3.6–5.2)4 1.3 (0.9–1.6) 1.4 (1.0–1.8) 3.5 (2.7–4.6) 6.7 (5.0–8.9)
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
820 ª 2002 Blackwell Science Ltd
The study population was divided into cases and
controls purely on the basis of presence or absence of
malaria parasites. Any false positives or false negatives
from the tests would bias the interpretation of the
protective effect of bednets. If people were pre-treated with
chloroquine before attending the clinic for diagnosis, some
cases would be misclassified as controls. Selection bias
would be introduced if the rate of pre-treatment with
chloroquine was different between net users and non-users.
Webster et al. (unpublished) showed that people from
Behsud who used a bednet were less likely to pre-treat with
chloroquine before attending clinic for malaria tests
(OR ¼ 0.26, P < 0.001). This pattern of behaviour
underestimated the effectiveness of bednets.
The assessment of protective effect is liable to confound-
ing if potential predictors of malaria risk such as economic
status or access to education differ between net users and
non-users. Socioeconomic status was not assessed, and this
was a weakness in our study designs. Recent evidence shows
that buyers of nets in Afghanistan are economically better off
(Howard & Rowland, unpublished). Yet, a difference in
wealth does not necessarily mean that net buyers and non-
buyers will differ in their risk of contracting malaria. Parasite
rate among buyers was similar to that among non-buyers at
the time of buying. Yet, by the end of the year, prevalence
was significantly lower among those who had been using
ITN during the course of the year.
The use of ITN can, in regions where vectors are
anthropophilic (e.g. East Africa), reduce survival of vectors
which would be shown by a decreased sporozoite rate and
a decreased vector density (Magesa et al. 1991). This
should have a beneficial effect on non-users as well as on
ITN users (Curtis et al. 1998). In Afghanistan, where the
vectors are zoophilic, mosquito density did not appear to
be reduced by ITN, and sporozoite rates were too low to
show the possibility of an indirect protective effect on non-
users (Rowland et al. 2002). Had there been such a
reduction, the effectiveness of bednets would have been
underestimated using the case–control methodology.
The local vector species are capable of transmitting both
species of malaria parasites (Rowland et al. 2002). It may
therefore be assumed that nets were equally protective
against P. falciparum and P. vivax transmission. Because an
effect against P. falciparum is immediate, the effect may be
measured through either cross-sectional methods or passive
data collection using a case–control design. But until it is
possible to distinguish new infections from relapsed infec-
tions, neither the cross-sectional nor passive surveillance
methods are adequate to show the real effect on P. vivax.
The effect is only demonstrable as a trend over time.
As Behsud and Chaprahar are considered to be typical
of rural Afghanistan, the study indicates that social
marketing of ITN is a viable malaria control strategy for
the country. Under the present uncertain conditions, it is
more appropriate to help people to protect themselves
than to return to the pre-war, centralized programmes of
DDT spraying that are too easily disrupted by crisis. For
families that are unwilling or unable to buy nets, an
alternative strategy must be found. Achieving high
coverage seems more a question of affordability than of
desirability. In a recent study, 90% coverage was
achieved when the price was set at US$1 per net
(T. Freeman, unpublished). This suggests that a dual
marketing strategy may offer the best prospect: After the
first wave of sales has swept over rural districts, it
should be possible to target the most endemic foci with
highly subsidized nets. Alternatively, the second phase
might target the most at risk by offering a highly
subsidized net to anyone who is diagnosed with malaria
at a public clinic. After the defeat of the Taliban and the
promise of the West to help rebuild Afghanistan, what
better use of aid than to provide the inhabitants with a
form of protection against malaria they so clearly want.
With the rural population at risk amounting to just a
few million (Anon 1998), and with double nets costing
about US$4 each (even less with cost-recovery), the aim
seems eminently achievable with the resources promised.
Acknowledgements
We would like to express our appreciation of microscopy
trainers Fazle Rahim, Aminullah and Sakhi Jan, entomol-
ogists Hamid Rahman, Mushtaq Faran and M. Kamal, and
logistician Noorullah. Clive Davies kindly advised us on
the analysis of entomological data. HealthNet Interna-
tional’s malaria control and research programme is sup-
ported by the European Commission (DG1), the United
Nations High Commissioner for Refugees, and WHO/
UNDP/World Bank Special Programme for Research and
Training in Tropical Diseases (project no. 960662). M.R.
and D.C. are supported by the UK Department for
International Development and the Gates Foundation.
However, none of these donors can accept responsibility
for any information provided or views expressed.
References
Abdulla S, Armstrong-Schellenberg JRM, Nathan R et al. (2001)
Impact on malaria morbidity of a programme supplying insec-
ticide treated nets in children aged under 2 years in Tanzania:
community cross sectional study. British Medical Journal 322,
270–273.
Anonymous. (1998) Consolidated Appeal for Afghanistan. United
Nations Children’s Fund UNICEF, New York.
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
ª 2002 Blackwell Science Ltd 821
Armstrong-Schellenberg JRM, Abdulla S, Nathan R et al. (2001)
Effect of large-scale social marketing of insecticide-treated nets
on child survival in rural Tanzania. Lancet 357, 1241–1247.
Chavasse D, Reed C & Attawell K (1999) Insecticide treated net
projects: a handbook for managers. Malaria Consortium,
London and Liverpool.
Choi HW, Breman JG, Teutsch SM, Lui S, Hightower AW &
Sexton JD (1995) The effectiveness of insecticide impregnated
bednets in reducing cases of malaria infection: a meta-analysis of
published results. American Journal of Tropical Medicine and
Hygiene 52, 377–382.
Clarke SE, Bogh C, Brown RC, Pinder M, Walraven GE &
Lindsay SW (2001) Do untreated bednets protect against
malaria? Transactions of the Royal Society of Tropical Medicine
and Hygiene 95, 457–462.
Curtis CF, Maxwell CA, Finch RJ & Njunwa KJ (1998) A
comparison of use of a pyrethroid either for house spraying or
for bednet treatment against malaria vectors. Tropical Medicine
and International Health 3, 619–631.
D’Alessandro U, OlaleyeBO, McGuire W et al. (1995) Mortality and
morbidity from malaria in Gambian children after introduction of
an impregnated bednet programme. Lancet 345, 479–483.
Lengeler C (1998) Insecticide treated bednets and curtains for mal-
aria control (Cochrane Review). The Cochrane Library, Issue 3.
Lengeler C & Snow RW (1996) From efficacy to effectiveness:
insecticide treated bednets in Africa. Bulletin of the World
Health Organization 74, 325–332.
Magesa SM, Wilkes TJ, Mnzava AEP et al. (1991) Trial of
pyrethroid impregnated bednets in an area of the United
Republic of Tanzania holoendemic for malaria. Part 2. Ef-
fects on the malaria vector population. Acta Tropica 49,
97–108.
Rab MA, Freeman TW, Durrani N, De Poerck D & Rowland MW
(2001) Resistance of Plasmodium falciparum malaria to chlor-
oquine is widespread in eastern Afghanistan. Annals of Tropical
Medicine and Parasitology 95, 591–602.
Rowland M, Bouma M, Ducornez D et al. (1996) Pyrethroid
impregnated bednets for self protection from malaria for Afghan
refugees. Transactions of the Royal Society of Tropical Medicine
and Hygiene 90, 357–361.
Rowland M, Hewitt S, Durrani N, Saleh P, Bouma M & Sondorp
E (1997) Sustainability of pyrethroid-impregnated bednets for
malaria control in Afghan communities. Bulletin of the World
Health Organization 75, 23–29.
Rowland M, Mohammed N, Rehman H et al. (2002) Mosquito
vectors and transmission of malaria in eastern Afghanistan.
Transactions of the Royal Society of Tropical Medicine and
Hygiene (in press).
Rowland M & Nosten F (2001) Malaria epidemiology and control
in refugee camps and complex emergencies. Annals of Tropical
Medicine and Parasitology 95, 645–658.
Shah I, Rowland M, Mehmood P et al. (1997) Chloroquine
resistance in Pakistan and the upsurge of falciparum malaria in
Pakistani and Afghan refugee populations. Annals of Tropical
Medicine and Parasitology 91, 591–602.
Webster J, Chandramohan D, Freeman T, Greenwood B &
Rowland M (2002) A health facility based case–control study of
effectiveness of insecticide treated nets: potential for selection
bias due to pre-treatment with chloroquine. Tropical Medicine
& International Health (in press).
Tropical Medicine and International Health volume 7 no 10 pp 813–822 october 2002
M. Rowland et al. Prevention of malaria through social marketing of insecticide-treated nets
822 ª 2002 Blackwell Science Ltd